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Abstract: This narrative review explores the relationship between sleep and nutrition. Various 
nutritional interventions have been shown to improve sleep including high carbohydrate, high 
glycaemic index evening meals, melatonin, tryptophan rich protein, tart cherry juice, kiwifruit and 
micronutrients. Sleep disturbances and short sleep duration are behavioural risk factors for 
inflammation, associated with increased risk of illness and disease, which can be modified to 
promote sleep health. For sleep to have a restorative effect on the body, it must be of adequate 
duration and quality; particularly for athletes whose physical and mental recovery needs may be 
greater due to the high physiological and psychological demands placed on them during training 
and competition. Sleep has been shown to have a restorative effect on the immune system, the 
endocrine system, facilitate the recovery of the nervous system and metabolic cost of the waking 
state and has an integral role in learning, memory and synaptic plasticity, all of which can impact 
both athletic recovery and performance. Functional food-based interventions designed to enhance 
sleep quality and quantity or promote general health, sleep health, training adaptations and/or 
recovery warrant further investigation. 
Keywords: sleep; athletes; chrononutrition. 
 
1. What is Sleep? 
Sleep, in humans, is defined as a complex reversible behavioural state where an individual is 
perceptually disengaged from and unresponsive to their environment [1]. Sleep architecture has two 
basic states based on physiological parameters: non-rapid eye movement sleep (NREM) and rapid 
eye movement (REM) sleep [2]. Sleep stages fall along a continuum from fully awake to deep sleep 
[3]. NREM has been defined as “a relatively inactive yet actively regulating brain in a moveable body” 
[2], (p.17). In terms of brain activity, the electroencephalogram (EEG) pattern of NREM sleep is 
commonly described as synchronous (increasing depth of sleep is indicated by progressive 
dominance of high voltage, low frequency EEG patterns), with characteristic waveforms (sleep 
spindles, K-complexes and high voltage waves) [2]. NREM is usually associated with minimal or 
fragmented mental activity. Table 1 shows the traditional four stages of NREM which are associated 
with differing levels of depth of sleep, with arousal thresholds generally lowest in Stage 1 and highest 
in Stage 4 sleep [2]. 
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Table 1. Characteristics of NREM Sleep. 
Stage Characteristics 
1 
Sleep is easily discontinued (e.g., noise, a light touch, etc.)  
Sleep is easily interrupted  
Key role in the initial wake to sleep transition 
Transitional stage throughout the sleep cycle 
2 
More intense stimuli required to produce arousal (e.g., bright light or loud noise) 
Indicated by K-complexes or sleep spindles in the EEG 
High voltage slow wave EEG activity will become apparent 
3 High voltage (75 μV) slow wave (two cycles per second [cps]) activity that is ≥ 20% but < 
50% of EEG activity 
4 High voltage slow wave activity is ≥ 50% of EEG activity. 
(Adapted from: [4]). 
In contrast, REM sleep is defined by EEG activation, muscle atonia (paralysis) and episodic 
bursts of rapid eye movement [2]. REM sleep is associated with cognitive activity, while brain stem 
mechanisms inhibit spinal motor neurons limiting movement. Hence, REM sleep has been defined as 
“an activated brain in a paralysed body” [2], (p.16). It should be noted that the American Academy 
of Sleep Medicine (AASM) have recommended alternative terminology for Sleep staging. Wake is 
referred to as W, NREM sleep is referred to as N and is divided into three stages: N1 – Stage 1, N2 – 
Stage 2 and N3 – Slow Wave Sleep or Deep Sleep, i.e., Stage 3 and 4 combined; while REM is referred 
to as R [5].  
Sleep health is a multidimensional pattern of sleep-wakefulness adapted to individual, social 
and environmental demands, which promotes physical and mental wellbeing [6]. Good sleep health 
is characterised by satisfaction, appropriate timing, adequate duration, high efficiency and sustained 
alertness during waking hours [6]. Sleep deprivation adversely affects glucose metabolism and 
neuroendocrine function which can affect carbohydrate metabolism, appetite, energy intake and 
protein synthesis [1]. These factors may negatively impact an athlete’s nutritional, metabolic and 
endocrine status impacting athletic performance and recovery [1], (e.g., impaired glucose metabolism 
could reduce glycogen repletion while impaired protein synthesis could reduce recovery and 
adaptation from training). This narrative review examines and evaluates the interaction between 
nutrition and sleep. 
1.1. How and Why Sleep Occurs 
The brain is essentially an electrical system with circuits that switch on and off to promote either 
wakefulness or sleep. Since the arousal and sleep-promoting systems are mutually inhibitory, a sleep 
switch or ‘flip-flop’ model has been proposed [7]. A flip-flop switch contains mutually inhibitory 
elements where activity in one of the competing sides shuts down inhibitory inputs from the other 
side producing two discrete states with sharp transitions [8]. Activation of arousal systems inhibits 
sleep active neurons facilitating sleep while activation of sleep-promoting neurons inhibits arousal-
related neurons reinforcing consolidated sleep episodes providing a mechanism for stabilisation of 
sleep and waking states [9]. 
The circadian rhythm in humans has been estimated in young males (24.18 ± 0.04 h; PCV 0.54%) 
and older adults (24.18 ± 0.04 h; PCV 0.58%), low percentage coefficients of variation and no 
significant difference between the groups indicated a small range variability in circadian rhythms 
[10]. Humans however, typically display individual differences in their behaviour (e.g., social 
activities, daytime activities and sleep). Chronotype is the expression of individual circadian 
rhythmicity and has been categorised as follows: morning types, intermediate types and evening 
types [11]. Chronotype is, in part, genetic but cultural and environmental factors also affect an 
individual’s sleep pattern. Research in the general population has demonstrated that most people are 
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intermediate types (70%) with the remainder being either morning types (14%) or evening types 
(16%) [12].  
Sleep is a dynamic process largely regulated by two factors; the circadian systems and the sleep 
homeostat. The Two Process Model for Sleep Regulation was developed to illustrate the interaction 
of the homeostatic sleep drive (sleep pressure or urge to sleep that accumulates during wakefulness) 
and the circadian system (endogenous timing system) in the timing and duration of sleep [13,14]. The 
homeostatic process (S) is a function of sleep and waking, while the circadian process (C) is controlled 
by a circadian oscillator [10]. S increases during waking and declines during sleep and it interacts 
with C, which is independent of sleep and waking and receives cues (e.g., light) from the environment 
[13,14]. The suprachiasmatic nucleus (SCN) in the brain is central to this process but secondary clock 
systems have been identified throughout the body [14].    
Process S is an endogenous mechanism, relying on exogenous cues to regulate it to 
approximately 24 h. Process S represents sleep debt which increases during waking and reduces 
during sleep within a range that oscillates within a period that is normally entrained to day and night 
by process C [14]. When S reaches the lower boundary of the range, awakening is triggered and when 
S reaches the upper boundary sleep is triggered [14]. In terms of process C, the Two-Process Model 
focuses on time-of-day effects on sleep propensity, specifically that sleep propensity is minimal near 
midday and is strongly promoted in the early hours of the morning [13]. This circadian rhythmicity 
in sleep propensity is combined with S by C dictating the threshold values at which S transitions from 
sleep to wake, and vice versa [13,14]. Core body temperature and melatonin rhythms are markers of 
C [11]. The SCN has melatonin receptor cells, as darkness falls, melatonin is secreted by the pineal 
gland making the individual sleepy [15]. Animal studies have demonstrated that exogenous 
melatonin and ramelteon (an MT1/MT2 melatonin receptor agonist) function as non-photic 
entrainers, which phase advance the SCN [16]. A Three-Process Model of Sleep Regulation has also 
been proposed whereby sleepiness and alertness are stimulated by the combined action of a 
homeostatic process, a circadian process and sleep inertia process, the model has been extended to 
include sleep onset latency (the length of time of the transition from wakefulness to sleep), sleep 
length and performance [17].   
Sleep has a restorative effect on the immune system and the endocrine system, facilitates the 
recovery of the nervous and metabolic cost of the waking state and has an integral role in learning, 
memory and synaptic plasticity (ability of synapses to strengthen or weaken over time) [18,19]. Sleep, 
particularly slow wave sleep (or N3) early in the night promotes prolactin release, while the anti-
inflammatory actions of cortisol and catecholamines are reduced [18]. Acute sleep deprivation and 
sleep disturbance (short sleep duration or reduced sleep efficiency) impair adaptive immunity which 
is associated with reduced response to vaccinations and increased vulnerability to infectious diseases, 
attributed to reduced growth hormone release during deep sleep and increased sympathetic output 
[20]. Tumour necrosis factor-ɑ (TNFɑ) along with other cytokines are considered key to the regulation 
of sleep in normal physiological conditions [21]. Research has demonstrated that sleep disturbance 
(i.e. insomnia) and extremes of sleep durations affect risk factors of inflammatory disease and 
contribute to all-cause mortality [18,22]. Increased levels of circulating inflammatory markers (i.e., C-
reactive protein [CRP] and Interleukin-6 [IL-6]) predict body mass gain in older adults [23] and type 
2 diabetes [24]. Sleep disturbance is believed to have proximal effects on IL-6, which induces CRP 
[18], therefore, increases in CRP may be attributed to persistent or severe sleep disturbance. In a 
recent meta-analysis sleep disturbance (i.e., poor sleep quality, insomnia) was associated with 
increased levels of IL-6 (ES: 0.20 (0.08–0.31)) and CRP (ES: 0.12 (0.05–0.19)) [18]. Short sleep duration 
(< 7 h per night) was associated with increased IL-6 (ES: 0.29 (0.05–0.52)), while long sleep duration 
(> 8 h per night) was also associated with increased IL-6 (ES: 0.11 (0.02–0.20)) but also increased CRP 
(ES: 0.17 (0.01–0.34)) [18]. Similarly, a meta-analysis of sleep duration and all-cause mortality 
demonstrated a U-shaped association, whereby long sleep (> 8 h per night) has a 30% (RR: 1.30 (1.22–
1.38)) greater risk while short sleep (<7 h per night) has a 12% (RR: 1.12 (1.06–1.18)) greater risk 
compared to normal sleep reference (7–8 h per night) [25]. 
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Inappropriate timing of lifestyle behaviours can cause disruption to the circadian rhythm, 
resulting in an altered physiological response (e.g., poor sleep). Lifestyle factors (e.g., caffeine 
consumption, alcohol consumption and timing of sleep) can cause alterations in environmental cues 
which may negatively impact circadian rhythms and in turn result in negative physiological 
consequences [26]. The SCN receives environmental cues such as the light-dark cycle and additional 
information from other areas of the brain (e.g., when we eat or exercise). Give that Process C can be 
modified by exogenous cues [27], there is scope for investigation of nutrition interventions to enhance 
sleep quality and quantity. Similarly, the effect of nutrition interventions that promote athlete 
recovery on sleep quality and quantity should be investigated.   
2. Sleep and Athletes 
The classic view of sleep is that it is a recovery process, with the circadian system regulating 
feelings of sleepiness and wakefulness throughout the day [28]. Cognition, tissue repair and 
metabolism are critical psychological and physiological factors that contribute to training capacity, 
recovery and ultimately performance [28]. The relationship between sleep, performance and recovery 
can be viewed in terms of 3 key factors that affect the recuperative outcome:  
1. Sleep length (total sleep duration; hours/night, plus naps) 
2. Sleep quality (i.e., the experience and perceived adequacy of sleep) 
3. Sleep phase (circadian timing of sleep) [28]. 
Post-exercise recovery is vital for all athletes. If the balance between training stress and physical 
recovery is inadequate, performance in subsequent training sessions or competition may be adversely 
affected [15]. Muscle fatigue or soreness may adversely affect sleep, with inflammatory cytokines 
linked to disruption of normal sleep [29]. Inadequate recovery can reduce autonomic nervous system 
(ANS) resources, with an associated reduction in heart rate variability (HRV) and increased resting 
heart rate [30]. Sleep deprivation is associated with increased catabolic and reduced anabolic 
hormones which results in impaired muscle protein synthesis [31], blunting training adaptations and 
recovery.  
Sleep disturbances and inadequate sleep duration have been reported in athletic populations. 
Assessment of the sleep patterns of professional male ice hockey players (n = 23) using 
polysomnography (PSG), demonstrated mean total sleep duration was 6.92 h; 95% CI 6.3–7.5 h [32]. 
Similarly, sleep was self-reported as the most important recovery modality utilised by South African 
athletes (n = 890; international n = 183, national n = 474, club n = 233) [15]. While a similar study found 
that 66% (n = 416) of elite German athletes (n = 632) reported pre-competition insomnia 
symptomology including difficulty falling asleep, waking during the night and early final waking 
times [33]. Sleep duration (< 8 h) has been identified as the strongest predictor of injury in adolescent 
athletes (RR = 2.1; 95% CI: 1.2–3.9) [34]. The Karolinska Athlete Screening Injury Prevention (KASIP) 
study investigated injury occurrence in Swedish adolescent elite athletes (n = 340; 178 males and 162 
females) and demonstrated that athletes sleeping >8 h were less likely to suffer an injury (OR: 0.39; 
95% CI 0.17–0.96) [35]. The aetiology of sleep disturbances is unclear during periods of intense 
training, it is unclear whether poor sleep is a symptom of overtraining, or intense training negatively 
affects sleep and recovery [30]. Sleep also has a pivotal role to play in performance, training 
adaptations and recovery [1,18]. Given the importance of sleep for athlete recovery, further research 
is warranted to investigate potential nutritional interventions to promote improved sleep quality 
and/or duration and recovery in athletes.  
2.1. Sleep, Nutrition and Athletes 
Nutrition support needs to be periodised in relation to the demands of the athlete’s daily training 
and overall nutritional goals [36]. The focus of ‘training’ nutrition is to promote adaptations while 
the focus of ‘competition’ nutrition is optimal performance [36]. Athletes also have added 
responsibility to adhere to the World Anti-Doping Agency (WADA) code and are subject to testing 
for prohibited substances. If an athlete chooses to take any supplement they must do so in a safe and 
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effective manner. Athletes should check that any supplement they take has been tested for banned 
substances, and independent testing programmes (e.g., Informed Sport and Informed Choice) offer 
additional protection. Athletes are advised to seek the professional advice of a qualified sports 
dietician/nutritionist regarding any nutritional supplement. Training adaptations and recovery can 
be maximised by optimal nutrition practices or impaired by suboptimal nutrition practices [36–38]. 
Nutrients such as carbohydrate (high glycaemic index evening meal reduced sleep onset latency), 
protein (consumption of dairy sources may increase sleep duration), ethanol (reduced REM sleep) 
[37] and caffeine (increased sleep onset latency, reduced total sleep duration and reduced sleep 
quality) [39], as well as the timing and quantity of meals (large portions and/or meals later in the 
evening can negatively impact sleep potentially due to the thermogenic effect of digestion) can affect 
circadian rhythms [40]. Caffeine consumption can lead to poor sleep which, in turn, can lead to 
increased caffeine consumption. Caffeine increases the state of alertness, antagonising adenosine 
receptors, which also leads to a reduction in the inclination to sleep [39]. Alcohol consumption has 
been associated with poorer sleep quality and quantity, reduced REM sleep and increased sleep 
disturbance in the second half of the sleep bout [41]. Similar to nutrition, sleep disturbances (difficulty 
initiating or maintain sleep) and sleep deprivation (not getting enough sleep) are risk factors for 
inflammation [18,42], which can be treated or managed to promote recovery and/or performance. For 
sleep to have a restorative effect on the body, it must be of adequate duration which is dependent on 
age [28,42]. Sleep recommendations particularly the amount of sleep required, change over the 
lifespan from adolescents (8–10 h), adults (7–9 h), and older adults (7–8 h) [42]. 
2.1. Chrononutrition 
Recently the term Chrononutrition has been used to describe the interaction between food and 
the circadian system [39]. It has been suggested that the internal clock can be altered by changing the 
timing and nature of food intake [39]. Chrononutrition has been characterised as including two 
aspects: 
1. Timing of food intake or contributions of food components to the maintenance of health; and 
2. Timing of food intake or contributions of food components to rapid changes in or resetting of a 
human’s system of internal clocks [39]. 
Several neurotransmitters are involved with the sleep-wake cycle including 5–
hydroxytryptophan (5-HT), GABA, orexin, melanin concentrating hormone, cholinergic, galanin, 
noradrenaline and histamine [7]. Therefore, nutrition interventions that act on these 
neurotransmitters could positively impact sleep. Dietary precursors can influence the rate of 
synthesis and function of neurotransmitters (e.g., serotonin synthesis is dependent on the availability 
of its precursor tryptophan in the brain) [1]. Tryptophan is transported across the blood brain barrier 
by a system that shares transporters with several large neutral amino acids (LNAA) [1]. The ratio of 
tryptophan:LNAA in the blood is vital to the transport of tryptophan into the brain and can be 
increased through consumption of tryptophan, a high carbohydrate/low protein diet or ɑ-lactalbumin 
(whey derived protein) [43]. 
2.1. Carbohydrate 
Carbohydrate consumption has been shown to increase plasma tryptophan concentrations [44]. 
Carbohydrates affect plasma tryptophan:LNAA ratio and may compliment the sleep enhancing effect 
of consuming tryptophan rich protein [40]. Insulin influences the transport of tryptophan across the 
blood brain barrier after a carbohydrate rich meal, as it is an anabolic agent it also facilitates the 
uptake of LNAA by muscle [26]. Consumption of high glycaemic index (GI) carbohydrate increases 
the ratio of circulating tryptophann:LNAA via direct action of insulin which promotes muscle uptake 
of LNAA [45]. This increases tryptophan availability for synthesis of serotonin and ultimately 
melatonin. GI has been shown to affect sleep onset latency (length of time of the transition from wake 
to sleep) [44]. A high GI meal consumed four hours before bed, significantly (p = 0.009) reduced sleep 
onset latency (9.0 ± 6.2 min) compared to a low GI meal (17.5 ± 6.2 min) and the same meal consumed 
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1 hour before bed (14.6 ± 9.9 min) [44]. Among a large sample (n = 4452) from the National Health 
and Nutrition Examination survey lower carbohydrate intake (24–h recall and structured interview) 
has been significantly associated (OR 0.71; 0.55–0.92, p = 0.01) with insomnia symptoms (difficulty 
maintaining sleep) [46]. Consumption of a high-carbohydrate meal (130 g) when compared to a low-
carbohydrate meal (47 g), or a meal containing no carbohydrate, 45 min before bedtime increased 
REM and decreased light sleep and wakefulness [47]. The timing of carbohydrate evening meals and 
the carbohydrate content of evening meal on sleep and athlete recovery requires further investigation 
within athletic populations.  
2.1. Melatonin 
Melatonin is a hormone secreted by the pineal gland, that has displayed sedative effects [48,49]. 
Since endogenous melatonin influences core temperature facilitating sleep, increased exogenous 
melatonin could affect changes in core temperature improving sleep quality [50]. However, the effect 
is relative to the person’s endogenous melatonin levels. In many Western countries, Cow’s milk has 
traditionally been considered a sleep promoting beverage. Melatonin is a naturally-occurring 
compound in cow’s milk, but its concentration increases significantly if cows are milked in darkness 
at night referred to as ‘night time milk’ [40]. Increased tryptophan and melatonin concentrations 
appear to be the property responsible for the sleep promoting effect of night time milk. Consumption 
of night time milk (melatonin concentration of 39.43 pg/mL) compared to daytime milk (4.03 pg/mL) 
significantly increased circulating melatonin (26.5%) concentration in rats [51], indicating that high 
melatonin concentrations are necessary for milk to affect blood melatonin concentrations. When the 
night time milk was supplemented with tryptophan (2.5 g/L) circulating melatonin concentrations 
significantly increased further (35.5%) [51].  
Melatonin has extremely low toxicity even at relatively high doses and can easily cross 
physiological barriers due to its optimal size, partial water solubility and high lipid solubility 
however, it must be noted that there appears to be no added benefit to doses >3 mg [49]. Ingestion of 
melatonin affects sleep propensity and has hypnotic effects enhancing sleep quality and duration, 
pharmacological melatonin can be used to manipulate circadian timing [49]. A positive effect of low 
doses (0.3 mg or 1 mg) of exogenous melatonin (gelatin capsules) on sleep onset latency has been 
observed in a small group of healthy males (n = 6), when administered at either 6:00 pm (0.3 mg 16.5 
± 19.9 min; 1 mg 12.3 ± 13.6 min; Placebo 23.1 ± 22.7 min) and 8:00 pm (0.3 mg 19.6 ± 14.1 min; 1 mg 
20.7 ± 17.7 min; Placebo 53.4 ± 51.9 min) [52]. However, the impact was time dependent as a 0.3 mg 
dose increased sleep onset latency when consumed at 9:00 pm (0.3 mg 25.1 ± 10.5 min; 1 mg 12.1 ± 7.4 
min; Placebo 8.8 ± 4 min) and there was no evidence of an effect when the 1 mg dose was administered 
at 9:00 pm [52]. The results indicate a low dose of melatonin similar to nocturnal physiological 
concentrations can elicit a sleep-inducing effect. A dose response relationship was not evident as the 
0.3 mg dose, which is similar to endogenous melatonin concentrations, was as effective as the 1 mg 
dose when administered at 6:00 pm or 8:00 pm.  
2.1. Tryptophan Rich Protein 
Tryptophan is an essential amino acid that is a precursor to serotonin and melatonin, which can 
cross the blood-brain barrier by competing for transport with other LNAA [1]. Conversion to 
serotonin is dependent on sufficient precursor availability in the brain, an increase in brain 
tryptophan occurs when the ratio of free tryptophan to branched chain amino acids increases, 
following tryptophan conversion to serotonin, melatonin is produced [1]. Dietary sources of 
tryptophan include milk, turkey, chicken, fish, eggs, pumpkin seeds, beans, peanuts, cheese, and 
leafy green vegetables. Dietary tryptophan has been shown to improve sleep, in a comparison of food 
bars (Food 1: 25 g deoiled butternut squash seed meal and 25 g dextrose, Food 2: 250 mg of 
pharmaceutical tryptophan and Food 3: 50 g rolled oats [control]) [53]. Food 1 and Food 2 produced 
significant results (p ≤ 0.05) for reduction of time awake during the night (19.2% and 22.1%), increased 
sleep efficiency (% of time spent in bed; asleep) (5.19% and 7.36%) and increased subjective sleep 
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quality (12.2% and 11.8%) [53], indicating that relatively small doses (250 mg) of dietary tryptophan 
can positively impact sleep. The milk protein, α-lactalbumin has been reported as having the highest 
natural levels of tryptophan among all protein food sources [54]. Ingestion of α-lactalbumin enriched 
whey protein, significantly (p < 0.05) increased tryptophan:LNAA by 48% compared to a casein 
enriched diet [54]. In a similar study, healthy adults (n = 14) with sleep complaints consumed 
milkshakes containing either α-lactalbumin (20 g) or a casein placebo. Evening ingestion of α-
lactalbumin resulted in a 130% increase in tryptophan:LNAA prior to bed and modest but significant 
reduction in morning sleepiness and improved alertness the following morning [55]. Tryptophan 
depletion studies have demonstrated decreased tryptophan plasma concentrations affected sleep 
fragmentation (arousal index (events/h)), REM sleep latency (the interval between first epoch of stage 
2 and the first epoch of REM sleep), and REM density (the cumulated duration of each REM burst 
divided by the duration of each REM sleep period) compared to baseline and placebo [56,57]. 
Consumption of tryptophan rich protein (e.g., milk) could affect changes in core temperature 
improving sleep quality [51]. The effects of tryptophan rich protein (e.g., α-lactalbumin enriched 
whey and casein) interventions on sleep and recovery, warrant further investigation. 
2.1. Antioxidants 
Both the general population and athletes can benefit from nutritional and supplementation 
support to boost immunity and reduce acute and chronic inflammation during periods of increased 
training load and competition. Antioxidants are any substance that significantly delay or prevent 
oxidative damage of a target molecule [58]. The fact that exercising muscles produce free radicals has 
motivated many athletes to consume antioxidant supplements in an attempt to reduce exercise 
induced free-radical damage and/or muscle fatigue. The antioxidant capacity of several dietary 
micronutrients is an emerging area of interest to support the endogenous antioxidant defence system 
of athletes and attenuate the negative effects of oxidative damage due to free radicals. Antioxidant 
consumption may influence recovery from exercise but may also influence sleep since sleep 
regulation is influenced by pro-inflammatory cytokines [59]. Dietary antioxidants (e.g., vitamin C 
and vitamin E) augment endogenous antioxidant content within skeletal muscle [59]. Vitamin E is a 
fat-soluble vitamin made up of several isoforms known as tocopherols, with ɑ-tocopherol being the 
most active and abundant [60]. Vitamin E is an important antioxidant due to its abundance within 
cells, mitochondrial membranes and its ability to act directly on reactive oxygen species [60]. Vitamin 
E reacts with other antioxidants such as vitamin C, beta-carotene and lipoic acid, which have the 
capacity to regenerate vitamin E from its oxidised form. However, supplementation with high doses 
(800 IU/day) of vitamin E did not counteract OS in triathletes (n = 38), the intervention group 
demonstrated significantly (p ≤ 0.05) higher levels of post-race inflammation and OS (Plasma F2-
isoprostanes increased 181% versus 97% and IL-6 166 ± 28 pg∙mL–1 versus 88 ± 13 pg∙mL–1) than the 
control group [60]. Interestingly, despite increased markers of OS and inflammation in the 
intervention group, there was no significant difference between the groups in terms of race 
performance.  
Vitamin A is a fat-soluble vitamin present in many lipid substances, beta-carotene can be 
converted into vitamin A, when necessary, from within the body [61]. Vitamin C is a water-soluble 
vitamin and is extremely effective in extracellular fluids, but is also effective in the cytosol [61]. It 
must be noted that antioxidants are heterogeneous, they function in a distinct manner and do not 
solely regulate ROS [61]. Consumption of an antioxidant does not guarantee that the compound will 
act as an antioxidant within the body, therefore positive findings from one antioxidant or 
combination of antioxidants cannot be generalised [59]. It has been suggested that a high intake of 
antioxidants could potentially reduce training adaptations. It is accepted that repeated exercise bouts 
(i.e. training) induce disruption in skeletal muscle homeostasis that regulate training adaptations 
[62,63]. While it has been reported that high doses of antioxidants could reduce training adaptations 
of muscle mitochondrial biogenesis and VO2max, not all antioxidant studies have demonstrated 
negative effects and it has been suggested that the specific antioxidant used, the dose and timing of 
ingestion all affect outcomes [64]. It must be noted that the majority of studies have been conducted 
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on healthy adults and there is inconsistency in terms of supplementation protocols, duration and also 
a wide variety of exercise protocols have been utilised. Antioxidants reduce OS, play a key role in 
immunity and may improve recovery following exercise [58,59]. Further research is necessary to 
investigate the recovery promoting doses of antioxidants within athletic populations [38,65]. The 
potential sleep promoting benefits of antioxidant consumption/supplementation should be 
investigated also. 
2.7.1. Tart Cherries 
Tart cherries contain high concentrations of melatonin and a range of phenolic compounds that 
have both antioxidant and anti-inflammatory properties [66,67]. A recent study was conducted to 
investigate the effect of tart cherry juice (2 × servings of 30 mL concentrate) on sleep enhancement, 
sleep duration and sleep quality [50]. This was the first investigation to demonstrate that tart cherry 
juice supplementation increased circulating melatonin levels and improved sleep time and quality in 
healthy adults. In the intervention group tart cherry juice supplementation resulted in significantly 
elevated total melatonin content, increased time in bed (+24 min), increased total sleep duration (+34 
min) improved sleep efficiency total (82.3%) and a significant reduction in daytime napping (–22%) 
(p < 0.05) [50]. It must be noted that elevated melatonin concentrations may not be only mechanism 
at work as sleep regulation is also influenced by proinflammatory cytokines [3]. Tart cherries also 
contain numerous compounds that have antioxidant and anti-inflammatory properties. A similar 
study demonstrated that tart cherry juice consumption resulted in significantly reduced insomnia 
severity index scores (13.2 ± 2.8 versus control 14.9 ± 3.6; p < 0.05) and wake after sleep onset time 
(62.1 ± 37.4 min versus control, 79.1 ± 38.6 mins; p < 0.01), in older females with insomnia (n = 7) 
compared to a placebo [68].  
Indeed, there is evidence that tart cherry juice supplementation post exercise may aid recovery 
from running a marathon [67]. The intervention group demonstrated a more rapid return of baseline 
isometric knee extension strength (pre-race 432 ± 114 vs. 48h 435 ± 109), 48 h post-marathon which 
was not demonstrated in the control group (pre-race 384 ± 112 vs. 48 h 349 ± 96) [67], indicating that 
consumption of tart cherry juice may blunt the secondary muscle damage response (localised 
inflammation). Post-race levels of inflammation were significantly reduced in the intervention group 
(IL-6 41.8 pg/mL) compared to the control group (IL-6 82.1 pg/mL) [67]. Similarly, post-race 
elevations in CRP and uric acid were significantly reduced in the intervention group (p < 0.001) [67]. 
Total antioxidant capacity was increased in both groups post-race (intervention 124% of baseline and 
control 112% of baseline, p < 0.01) and remained elevated at 24 h in the intervention group (114% of 
baseline) but not the control group [67]. During recovery athletes can suffer from delayed onset 
muscle soreness (DOMS) [66], which can reduce sleep quantity and quality. A recent study has 
demonstrated tart cherry juice supplementation (30 mL, twice per day for seven days) reduced the 
post-exercise decline in functional performance following intermittent sprint activity (maximal 
voluntary isometric contractions, 20 m sprint, counter movement jump and 505 agility test), DOMS 
and inflammatory response (Il-6) [66]. With regards the reduction in both DOMS and the post-
exercise inflammatory response, in practice, the researchers suggested that this might be beneficial 
during periods of high-volume training (e.g., pre-season) or where athletes are required to produce 
multiple performances in a short space of time (e.g., double training sessions), when recovery periods 
are short [66]. The range of phenolic compounds in cherries which have anti-inflammatory and 
antioxidant properties may enhance post exercise recovery as well as sleep [50]. It has been proposed 
that melatonin may be synthesised in mitochondria, making melatonin and its metabolites available 
to protect the muscle against oxidative stress. Melatonin also increases the protective effects of 
glutathione, vitamin C and trolox, through regeneration by electron transfer processes [69]. 
2.7.2. Kiwifruit 
Kiwifruit are nutritionally dense containing a range of nutrients that can benefit sleep, health 
and recovery including serotonin, vitamin C, vitamin E, vitamin K, folate, anthocyanidins, 
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carotenoids, beta-carotene, lutein, potassium, copper and fibre [70]. Interest in the antioxidant 
capacity, enzyme, polyphenolic and phytochemical content of kiwifruit has increased steadily over 
the last decade [70–72]. It has been suggested that the various bioactive components in kiwifruit may 
act synergistically affecting various physiological and metabolic processes (e.g., inhibition of 
oxidative and inflammatory responses, improved gastrointestinal tract health and bowel function) 
[73]. Contemporary research has focused on the health benefits of kiwifruit particularly in relation to 
antioxidant capacity, digestion, iron nutrition, metabolic health and immune function [73]. 
Regular consumption of kiwifruit has been found to significantly (p ≤ 0.05) increase plasma 
vitamin C [74] vitamin E [71] and lutein/zeaxanthin concentrations [71,74]. A study involving 
volunteers (n = 25) with a self-reported sleep disturbance demonstrated consumption of two kiwifruit 
one hour before bedtime for four weeks significantly improved actigraphy-measured total sleep 
duration (+16.9%, baseline 354.5 ± 17.1 min; post-intervention 395.3 ± 17.4 min) and sleep efficiency 
(+2.4%, baseline 93.9 ± 1.03 min; post-intervention 95.9 ± 0.67 min) (p ≤ 0.005) [70]. Self-report 
measures also improved significantly, wake after sleep onset reduced (time awake during sleep 
period) (–28.9%), sleep onset latency reduced (–35.4%) while sleep efficiency increased (5.4%) (p ≤ 
0.002) [70]. Sleep quality was significantly improved following the four-week kiwifruit intervention 
however, the lack of a control group must be noted and there was a high level of subject drop out (n 
= 5). The findings may be prone to bias as subjects were recruited based on interest in participation 
in a dietary intervention study relating to sleep. 
Serotonin is the end product of L-tryptophan metabolism and is related to REM [70]. The 
serotonin content in kiwifruit may contribute to improved sleep while the rich antioxidant content 
may supress free radical expression and inflammatory cytokines. Folate deficiency has been linked 
to insomnia (difficulty initiating or maintaining sleep, extended periods of wakefulness and/or 
insufficient sleep) and restless leg syndrome (repeated movement of or undesirable sensations in legs 
leading to sleep disruption) [70], the high folate content in kiwifruit may improve folate status and 
consequently improve sleep [70]. Although folates are widely consumed in the diet, they are 
destroyed by cooking or processing, however, kiwifruit are typically consumed in their raw form. 
Further research is warranted within athletic populations to investigate the potential sleep promoting 
properties of kiwifruit and the effect of kiwifruit consumption on both sleep quality, sleep quantity 
and recovery.  
2.7. B Vitamins and Magnesium 
Vitamin B12 contributes to melatonin secretion, pyridoxine (vitamin B6) is involved in the 
synthesis of serotonin from tryptophan and niacin (vitamin B3) may elicit a tryptophan sparing effect 
[40]. Niacin can be synthesised endogenously from tryptophan via the Kynurenine Pathway, 
therefore, consuming a sufficient amount of niacin is necessary to inhibit 2,3-dioxygenase activity 
eliciting a tryptophan sparing effect, increasing its availability for synthesis serotonin and melatonin 
[40]. Folate (vitamin B9) and pyridoxine are involved in the conversion of tryptophan into serotonin 
[45]. The reduced form of folate (5-methyltetratrahydrofolate) increases tetrahydrobiopterin is a co-
enzyme of tryptophan-5-hydroxylase which converts tryptophan into 5-hydroxytryptamine (5-HT) 
[45]. Pyridoxine’s role in the conversion of tryptophan into serotonin is related to the amino acid 
decarboxylase which speeds up the conversion rate of 5-HT to serotonin [45]. Mixed effects have been 
observed, with different doses of cobalamin (vitamin B12) on sleep-wake rhythms and delayed sleep 
phase syndrome (a significant delay in circadian rhythm), while no effect was observed for sleep 
duration [41]. 
Magnesium is also believed to enhance melatonin secretion promoting sleep onset and act as a 
GABA agonist, the main inhibitory neurotransmitter that acts on the CNS [40]. Magnesium is 
important for the production of the enzyme N-acetyltransferase which converts 5-HT into N-acetyl-
5-hydroxytryptamine, which can then be converted to melatonin [44]. A placebo controlled double 
blind study on older adults (n = 43), demonstrated a food based supplement containing 5 mg 
melatonin, 225 mg magnesium and 11.25 mg zinc, significantly (p < 0.001) improved subjective sleep 
quality scores in the intervention group but not the controls (difference between the groups 6.8; 95% 
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CI 5.4–8.3) and total sleep duration (182.18 min; 95% CI 160.02–204.34) assessed via actigraphy [75]. 
The effects were attributed to the synergy between magnesium, zinc and melatonin [75]. It must be 
noted that supplementing these nutrients will most likely only have an effect in cases of deficiency 
or insufficiency.   
3. Conclusion 
Nutrients such as antioxidants, tryptophan rich protein, carbohydrate, melatonin, 
micronutrients and fruit can affect sleep [37,39,40]. Sleep can be promoted either by inhibiting wake-
promoting mechanisms or by increasing sleep promoting factors through nutritional interventions 
[40]. Based on this review of the existing scientific literature, there appears to be considerable scope 
for further investigation of nutrition interventions designed to enhance sleep quality and quantity or 
promote general health, sleep health, training adaptations and/or recovery in both general and 
athletic populations.  
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